South Yorkshire Local Peer Support Group
Saturday 24 May, 12.00pm - 2.00pm - In-person - Come and join us for our second in-person get together at Endcliffe Park in Sheffield for a leisurely walk followed by coffee and a bite to eat at their cafe.
Search
Search results
Buckinghamshire Local Peer Support Group
Thursday 12 June, 12.00pm - 2.00pm - In-person - Come and join us for our latest in-person get together at Vale Park in Aylesbury for a leisurely walk followed by coffee and a bite to eat at the Aqua Vale Centre cafe.
‘Talking’ Tech Peer Support Group
Thursday 15 May 2025, 7.00pm - 8.00pm - via Zoom - Come and join us for our latest meeting where we will be joined by our guest speakers and new sponsors, EMVI - A Mobile Visual Assistant Designed by and for the Visually Impaired.
Manchester Local Peer Support Group
Saturday 31 May 2025, 12.00pm - 5.00pm - In-person - Come and join Rachael and the group at The Waldorf Pub in Manchester with guest speakers Anthony Gough and Richard Zimbler, Trustees at North Wales Accessible Holidays for Blind and Visually Impaired.
Involving our community
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
Meet a researcher: Chloe Brotherton
As part of our aim to nurture young scientists, we are very pleased to introduce one of our new PhD students as part of a co-funding agreement with the Macular Society.
Meet our supporters: William Taylor
Fundraising for Retina UK means a lot to me - both my dad and my nephew have been affected by inherited sight-loss, and I've seen first-hand the incredible work this charity does.
SB-007, we’ve been expecting you
Introducing Splice Bio, a genetic medicines company with some exciting developments for Stargardt’s patients.
Mirugen – Unlocking the Power of Retina Regeneration
Mirugen – Unlocking the Power of Retina Regeneration
Gene therapy treatment Luxturna accepted for use in Scotland
Retina UK is delighted that the Scottish Medicines Consortium (SMC) has accepted the gene therapy Luxturna (voretigene neparvovec) for ongoing use by the NHS in Scotland.